Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Drug candidates can block pathway associated with cell death in Parkinson's disease

  • MRIs link impaired brain activity to inability to regulate emotions in autism

  • Neuroscience researchers believe in quitting smoking gradually

  • Brain white matter changes seen in children who experience neglect

  • Study of former NFL players reveals specifics of concussive brain damage

  • Brain study sheds light on how children with autism process social play

  • Cochlear implant users can hear, feel the beat in music

  • In infants, pain from vaccinations shows up in brain activity

  • Testosterone helps bind antidepressants in brain

  • Lead negatively impacts cognitive functions of boys more than girls

  •